Risk of Post-polypectomy Bleeding With Prophylactic Hemoclipping
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Linda A Feagins
VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Va North Texas Health Care System Dallas Va Medical Center, Dallas, Tx
Dallas, Texas, United States
- South Texas Health Care System, San Antonio, Tx
San Antonio, Texas, United States
- Central Texas Veterans Health Care System, Temple, Tx
Temple, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Sept 2011
- Primary completion
- 1 Nov 2018
- Completion
- 1 Nov 2018
- Last update posted
- 15 Oct 2019
- Registered enrollment
- 11,182
- Registry id
- NCT01647581
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.